{
    "ALL":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent or other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },





              

    "over_18_initiation_no_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
              {
                    "label": "Documented baseline body mass index (BMI) ≥ 27 kg/m^2.",
                    "validation": "An initial BMI of less than 27 kg/m^2 is unlikely to be approved."
              },
              {
                    "label": "Document the patient has not tried a targeted weight loss agent in the past 12 months.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },
    "over_18_initiation_with_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
             "items": [
               {
                    "label": "Documented baseline body mass index (BMI) ≥ 27 kg/m^2.",
                    "validation": "An initial BMI of less than 27 kg/m^2 is unlikely to be approved."
               },
               {
                    "label": "Document the patient has tried a targeted weight loss agent for a previous course of therapy in the past 12 months AND the prescriber anticipates success with repeating therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
               }
               {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
             ]
        },
    "over_18_initiation_south_asian_no_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
              {
                    "label": "Documented baseline body mass index (BMI) ≥ 25 kg/m^2.",
                    "validation": "An initial BMI of less than 25 kg/m^2 is unlikely to be approved."
              },
              {
                    "label": "Document the patient has not tried a targeted weight loss agent in the past 12 months.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },
    "over_18_initiation_south_asian_with_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
              {
                    "label": "Documented baseline body mass index (BMI) ≥ 25 kg/m^2.",
                    "validation": "An initial BMI of less than 25 kg/m^2 is unlikely to be approved."
              },
              {
                    "label": "Document the patient has tried a targeted weight loss agent for a previous course of therapy in the past 12 months AND the prescriber anticipates success with repeating therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },
    

               


    "below_18_initiation_no_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document the patient has a diagnosis of obesity, confirmed by a body mass index (BMI) ≥ 85th percentile for age and gender.",
                    "validation": "Wegovy is unlikely to get approved for BMI below 85th percentile."
                },
            {
                    "label": "Document the patient has not tried a targeted weight loss agent in the past 12 months.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent or other weightloss agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },
    "below_18_initiation_with_weightloss_agent":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document the patient has a diagnosis of obesity, confirmed by a body mass index (BMI) ≥ 85th percentile for age and gender.",
                    "validation": "Wegovy is unlikely to get approved for BMI below 85th percentile."
                },
                {
                    "label": "Document the patient has tried a targeted weight loss agent for a previous course of therapy in the past 12 months AND the prescriber anticipates success with repeating therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
                  },
              {
                    "label": "Document that the patient has been on a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications for a minimum of 6 months prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient did not achieve a weight loss of 1 pound or more per week while on the weight loss regimen prior to initiating therapy with Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
            {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent or other weightloss agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient is newly starting therapy or has received less than 52 weeks (1 year) of therapy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              }
            ]
        },


    




    "over_18_continuation_under_52_weeks":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document patient has recieved less than 52 weeks of therapy on the 2.4mg dose.",
                    "validation": "Wegovy is unlikely to get approved for use over 52 weeks."
                },
                {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
                }
            ]
        },

        "over_18_continuation_over_52weeks":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document patient has achieved and is maintained a reduction of BMI of at least 5% from baseline.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission.."
                },                
                {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
                }
            ]
        },
    "below_18_continuation_over_52weeks":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document patient has achieved and is maintained a reduction of BMI of at least 5% from baseline.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission.."
                },
                {
                    "label": "Document current BMI is greater than 85th percentile for age and gender.",
                    "validation": "A current BMI of less than 30 kg/m^2 is unlikely to be approved."
                },
                {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
                }
            ]
        },
    "below_18_continuation_under_52weeks":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
                {
                    "label": "Document patient has recieved less than 52 weeks of therapy on the 1.7 or 2.4mg dose.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission.."
                },
                {
                    "label": "Document current BMI is greater than 85th percentile for age and gender.",
                    "validation": "A current BMI of less 85th percentile is unlikely to be approved."
                },
                {
                    "label": "Document the patient will NOT be using Wegovy in combination with other weightloss medications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
                }

    "All_continuation":
        {
            "header": "Verify Prescriber and Patient Documentation",
            "items": [
              {
                    "label": "Document the patient is currently on and will continue a weight loss regimen of a low-calorie diet, increased physical activity, and behavioral modifications.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 or have a history of pancreatitis.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document that the patient does NOT have a known hypersensitivity to semaglutide or any of the ingredients in Wegovy.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "The patient has been previously approved for Wegovy through the plan's Prior Authorization process.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "The requested dose is 1.7mg or 2.4mg.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },
              {
                    "label": "Document the patient will NOT be using Wegovy in combination with another GLP-1 receptor agonist agent or other weightloss agent.",
                    "validation": "Stop and contact provider to document this in the patient's chart. Add to your PA submission."
              },

